I'm LongbridgeAI, I can summarize articles.Can-Fite BioPharma（CANF.US）现价 $2.940，当日 -1.67%，盘中 5 分钟涨幅曾超 3%，市值 0.04 亿。企业聚焦创新药物研发，近期临床 2a 期积极数据推动股价剧烈波动。此前合作方 Vetbiolix 完成骨关节炎项目入组，市场关注后续试验进展。
Can-Fite BioPharma (CANF.US) is trading at $2.940, down -1.67% intraday, with a 5-minute spike previously above 3%. Market cap is 4 million.
The company specializes in novel drug research, with recent positive Phase 2a clinical results driving sharp price swings. Vetbiolix recently completed enrollment for a canine osteoarthritis study, and investors are watching upcoming trial updates.